Received Apr 22, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
mild discomfort at injection site; some mild fatigue for a day or two; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of injection site discomfort in a 64-year-old patient who received Herpes zoster (Shingles vaccine) for prophylaxis. The patient's past medical history included shingles and post herpetic neuralgia. On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced injection site discomfort (Verbatim: mild discomfort at injection site) and fatigue (Verbatim: some mild fatigue for a day or two). The outcome of the injection site discomfort and fatigue were resolved. It was unknown if the reporter considered the injection site discomfort and fatigue to be related to Shingles vaccine. It was unknown if the company considered the injection site discomfort and fatigue to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 12-APR-2025 This case was reported by a patient via interactive digital media Consumer reported that he/she 64 years old and had shingles over a year ago. But still had nerve pain (post herpetic neuralgia) from the shingles even though the blisters had been long gone. Physician was advised to patient take the vaccine to reduce the chances of having the shingles a second time. Patient had the vaccine and had very few side effects, mild discomfort at injection site and some mild fatigue for a day or two, but nothing. The follow-up could not be possible as no contact details were available.
Medical History/Concurrent Conditions: Post herpetic neuralgia; Shingles